
Cardiac Biomarker Diagnostic Kits Market by Disease (Angina Pectoris, Cardiac Heart Failure, Myocardial Infraction), Testing (Laboratory Testing, Point of Care Testing), Product, End-User - Global Forecast 2024-2030
Description
Cardiac Biomarker Diagnostic Kits Market by Disease (Angina Pectoris, Cardiac Heart Failure, Myocardial Infraction), Testing (Laboratory Testing, Point of Care Testing), Product, End-User - Global Forecast 2024-2030
The Cardiac Biomarker Diagnostic Kits Market size was estimated at USD 3.78 billion in 2023 and expected to reach USD 4.11 billion in 2024, at a CAGR 8.93% to reach USD 6.88 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Cardiac Biomarker Diagnostic Kits Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cardiac Biomarker Diagnostic Kits Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Cardiac Biomarker Diagnostic Kits Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Atlas Medical GmbH, Beckman Coulter, Inc., Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., bioMérieux SA, Creative Diagnostics, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Guangzhou Wondfo Biotech Co., Ltd., Lepu Medical Technology (Beijing) Co., Ltd., LSI Medience Corporation, MP Biomedicals, LLC, PerkinElmer, Inc., Randox Laboratories Ltd., Siemens Healthcare GmbH, and Thermo Fisher Scientific, Inc..
Market Segmentation & Coverage
This research report categorizes the Cardiac Biomarker Diagnostic Kits Market to forecast the revenues and analyze trends in each of the following sub-markets:
Disease
Angina Pectoris
Cardiac Heart Failure
Myocardial Infraction
Testing
Laboratory Testing
Point of Care Testing
Product
BNP Test Kit
C-Reactive Protein
CK-MB Test Kits
Myoglobin Test Kits
Troponin Test Kits
End-User
Clinics
Diagnostics Centers
Hospitals
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Cardiac Biomarker Diagnostic Kits Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cardiac Biomarker Diagnostic Kits Market?
3. What are the technology trends and regulatory frameworks in the Cardiac Biomarker Diagnostic Kits Market?
4. What is the market share of the leading vendors in the Cardiac Biomarker Diagnostic Kits Market?
5. Which modes and strategic moves are suitable for entering the Cardiac Biomarker Diagnostic Kits Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
182 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Cardiac Biomarker Diagnostic Kits Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing cases of cardiovascular diseases worldwide
- 5.1.1.2. Rising geriatric population and the consequent increase in the burden of chronic diseases
- 5.1.1.3. Growing consumer preference for early diagnosis and treatment
- 5.1.2. Restraints
- 5.1.2.1. Concerns related to sample collection and storage
- 5.1.3. Opportunities
- 5.1.3.1. Increase in R&D efforts for new developments
- 5.1.3.2. Growing trend of Point-of-care testing (POCT)
- 5.1.4. Challenges
- 5.1.4.1. Lack of supportive reimbursement policies
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Cardiac Biomarker Diagnostic Kits Market, by Disease
- 6.1. Introduction
- 6.2. Angina Pectoris
- 6.3. Cardiac Heart Failure
- 6.4. Myocardial Infraction
- 7. Cardiac Biomarker Diagnostic Kits Market, by Testing
- 7.1. Introduction
- 7.2. Laboratory Testing
- 7.3. Point of Care Testing
- 8. Cardiac Biomarker Diagnostic Kits Market, by Product
- 8.1. Introduction
- 8.2. BNP Test Kit
- 8.3. C-Reactive Protein
- 8.4. CK-MB Test Kits
- 8.5. Myoglobin Test Kits
- 8.6. Troponin Test Kits
- 9. Cardiac Biomarker Diagnostic Kits Market, by End-User
- 9.1. Introduction
- 9.2. Clinics
- 9.3. Diagnostics Centers
- 9.4. Hospitals
- 10. Americas Cardiac Biomarker Diagnostic Kits Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Cardiac Biomarker Diagnostic Kits Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa Cardiac Biomarker Diagnostic Kits Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. Abbott Laboratories
- 14.1.2. Atlas Medical GmbH
- 14.1.3. Beckman Coulter, Inc.
- 14.1.4. Becton, Dickinson, and Company
- 14.1.5. Bio-Rad Laboratories, Inc.
- 14.1.6. bioMérieux SA
- 14.1.7. Creative Diagnostics
- 14.1.8. DiaSorin S.p.A.
- 14.1.9. F. Hoffmann-La Roche Ltd.
- 14.1.10. Guangzhou Wondfo Biotech Co., Ltd.
- 14.1.11. Lepu Medical Technology (Beijing) Co., Ltd.
- 14.1.12. LSI Medience Corporation
- 14.1.13. MP Biomedicals, LLC
- 14.1.14. PerkinElmer, Inc.
- 14.1.15. Randox Laboratories Ltd.
- 14.1.16. Siemens Healthcare GmbH
- 14.1.17. Thermo Fisher Scientific, Inc.
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
- FIGURE 1. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET RESEARCH PROCESS
- FIGURE 2. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2023 VS 2030
- FIGURE 3. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET DYNAMICS
- FIGURE 7. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
- FIGURE 8. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2023 VS 2030 (%)
- FIGURE 10. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY TESTING, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 12. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 14. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. AMERICAS CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 18. UNITED STATES CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ASIA-PACIFIC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. ASIA-PACIFIC CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 24. CARDIAC BIOMARKER DIAGNOSTIC KITS MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.